Liquidia Technolgies, Inc. v. United Therapeutics Corp. > Summary
Court Case Number IPR2020-00770
Filing Date Mar 30, 2020
Institution Decision Date Oct 13, 2020
Decision Date Oct 8, 2021
Court Patent Trial and Appeal Board
Status Final Written Decision
Appeal2022-2133
Administrative JudgesZhenyu Yang, Erica A. Franklin, John E. Schneider
Judge Writing the Final DecisionZhenyu Yang
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9
Claims Invalidated: 1, 2, 3, 4, 5, 8, 9
Petitioner
Patent Owner
Petitioner Attorneys
6Liquidia Corporation
Attorney Name: Ivor R. Elrifi
Cooley LLP
Liquidia Corporation
Attorney Name: Erik B. Milch
Cooley LLP
Liquidia Corporation
Attorney Name: Deepa Kannappan
Cooley LLP
Liquidia Corporation
Attorney Name: Sanya Sukduang
Cooley LLP
Liquidia Corporation
Attorney Name: Jeffrey D. Winkler
Cooley LLP
Liquidia Corporation
Attorney Name: Robert Ruffolo Jr.
Cooley LLP
Patent Owner Attorneys
10United Therapeutics
Attorney Name: George E. Quillin
Foley & Lardner LLP
United Therapeutics
Attorney Name: Daniel R. Shelton
Foley & Lardner LLP
United Therapeutics
Attorney Name: Douglas H. Carsten
Wilson Sonsini Goodrich & Rosati
United Therapeutics
Attorney Name: Richard L. Torczon Jr.
Wilson Sonsini Goodrich & Rosati
United Therapeutics
Attorney Name: Shaun R. Snader
United Therapeutics
United Therapeutics
Attorney Name: Judy Michele Mohr
McDermott Will & Emery
United Therapeutics
Attorney Name: April E. Weisbruch
McDermott Will & Emery
United Therapeutics
Attorney Name: Jason N. Mock
Foley & Lardner LLP
United Therapeutics
Attorney Name: Rodolfo Pinal
Foley & Lardner LLP
Related Patents
Doc No | Title | Issue date |
---|---|---|
09604901 | Process to prepare treprostinil, the active ingredient in Remodulin® | Mar 28, 2017 |